Chalcogen Bonded Directly At The 11-position Of The Cyclopentanohydrophenanthrene Ring System Patents (Class 540/20)
  • Patent number: 7642356
    Abstract: The present invention relates to a process for preparing a beta-keto ester compound of formula (1), which is an intermediate for the synthesis of quinolone antibiotics. Particularly, the present invention is characterized by the reaction of an organo nitrile compound with a salt of mono-alkyl malonate in the presence of metal salt, and so the reaction is easy to control due to its endothermic nature, and is devoid of lachrymatory reagents with excellent reproducibility. Subsequent in situ hydrolysis in the presence of aqueous acid solution provided the compound of formula (1).
    Type: Grant
    Filed: September 15, 2006
    Date of Patent: January 5, 2010
    Assignee: LG Life Sciences Ltd.
    Inventors: Hyun Ik Shin, Bo Seung Choi, Jae Hoon Lee
  • Patent number: 5939398
    Abstract: This invention relates to certain steroidal glycosides useful as hypocholesterolemic agents and antiatherosclerosis agents and certain protected intermediates useful in the preparation of said steroidal glycosides.
    Type: Grant
    Filed: January 20, 1998
    Date of Patent: August 17, 1999
    Assignee: Pfizer Inc.
    Inventor: Michael Paul Deninno
  • Patent number: 5731447
    Abstract: A process for the preparation of a compound of the formula ##STR1##
    Type: Grant
    Filed: June 10, 1996
    Date of Patent: March 24, 1998
    Assignee: Roussel Uclaf
    Inventors: Jean Buendia, Patrick Roussel, Michel Vivat
  • Patent number: 5563259
    Abstract: A process for the synthesis of peracyl-1-O-steroidal-.beta.-cellobiosides that provides excellent .beta.-anomeric selectivity without the use of a metal salt promoter. The process comprises reacting heptaacyl-.beta.-D-cellobiosyl-1-fluoride and a trisubstituted silyl-3-O-steroid, wherein the steroid is tigogenin, hecogenin, 11-ketotigogenin or diosgenin in the absence of a metal salt under suitable conditions.
    Type: Grant
    Filed: December 20, 1994
    Date of Patent: October 8, 1996
    Assignee: Pfizer Inc.
    Inventors: Kathleen D. Goggin, John F. Lambert, Stanley W. Walinsky